NRx Pharmaceuticals Inc. (NRXPW)
NASDAQ: NRXPW
· Real-Time Price · USD
0.10
0.01 (11.11%)
At close: Jun 09, 2025, 3:41 PM
NRx Pharmaceuticals Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -1.53 | -0.71 | -2.86 | -0.86 | -1.78 | -22.28 | -8.79 | -10.16 | -8.79 | -32.23 | -13.62 | -22.59 | -34.85 | -20.08 | -61.15 | -75.72 | -123.88 |
PEG Ratio | 0.03 | -0.00 | 0.04 | -0.64 | -0.00 | 0.74 | 0.23 | 0.28 | -0.07 | 0.84 | -0.12 | 0.36 | 0.50 | -0.35 | n/a | 1.63 | 1.29 |
PS Ratio | n/a | 6.46K | n/a | n/a | n/a | 48.25K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | -1.34 | -1.11 | -0.99 | -1.48 | -3.08 | -32.9 | -34.27 | -126.21 | -1.57K | 99.56 | 29.30 | 15.56 | 49.22 | 118.87 | 566.60 | -278.07 | 10.35K |
P/FCF Ratio | -9.67 | -12.32 | -8.04 | -7.74 | -12.66 | -121.09 | -46.66 | -45.38 | -72.96 | -88.69 | -78.41 | -26.66 | -150.23 | -219.24 | -422.75 | -425.48 | -4.19K |
P/OCF Ratio | -9.67 | -12.32 | -8.04 | -7.74 | -12.66 | -120.94 | -46.68 | -45.37 | -73 | -88.68 | -78.48 | -26.66 | -150.27 | -219.25 | -422.88 | -425.58 | -4.19K |
OCF/S Ratio | n/a | -524.5 | n/a | n/a | n/a | -399 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | n/a | -0.28 | -0.35 | -0.47 | -0.45 | -0.78 | -1.62 | -4.52 | -42.92 | 1.42 | n/a | n/a | 0.02 | 0.02 | 0.06 | -0.04 | 2.34 |
Quick Ratio | 0.22 | 0.15 | 0.20 | 0.21 | 0.18 | 0.36 | 0.68 | 0.88 | 0.99 | 1.66 | 3.15 | 4.66 | 3.66 | 2.74 | 1.25 | 0.52 | 0.09 |
Current Ratio | 0.22 | 0.15 | 0.20 | 0.21 | 0.18 | 0.36 | 0.68 | 0.87 | 0.99 | 1.66 | 3.08 | 4.58 | 3.66 | 2.74 | 1.25 | 0.52 | 0.09 |
Asset Turnover | n/a | 0.00 | n/a | n/a | n/a | 0.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | n/a | -26.08 | -55.08 | -145.2 | n/a | -5.88 | n/a | n/a | n/a | -5.24K | -22.6K | -3.74K | -3.35K | -5.12K |
Return on Equity | 0.22 | 0.39 | 0.09 | 0.43 | 0.43 | 0.37 | 0.98 | 3.10 | 44.52 | -0.77 | -0.54 | -0.17 | -0.35 | -1.48 | -2.32 | 0.92 | -20.89 |
Return on Assets | -0.73 | -2.49 | -0.36 | -1.5 | -1.72 | -0.59 | -0.46 | -0.44 | -0.58 | -0.22 | -0.36 | -0.13 | -0.26 | -0.94 | -0.46 | -0.86 | -4.23 |
Return on Invested Capital | 0.15 | 0.15 | 0.25 | 0.72 | 0.72 | 1.16 | -1.52 | -0.8 | -0.91 | -0.31 | -0.54 | -0.24 | -0.41 | -2.05 | -2.12 | 17.35 | -0.56 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | 0.50 | n/a | n/a | n/a | 0.88 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | -2.27K | n/a | n/a | n/a | -541.5 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | -2.27K | n/a | n/a | n/a | -541.5 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | -608 | n/a | n/a | n/a | -550.75 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | -2.27K | n/a | n/a | n/a | -531.38 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |